Delivery Order SPE2DB20D2104-SPE2DB23FS11S
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 units of the medication Valganciclovir 450 mg tablets, with a ceiling value of $2,585.74 and a completion date of July 7, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 450 mg valganciclovir tablets, a medication used to treat cytomegalovirus infections. The contract has a ceiling value of $5,341.60 and a period of performance through June 11, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valganciclovir 450 mg tablets, with a total ceiling value of $15,535.37 and a period of performance through March 12, 2025. The contract is not designated as a set-aside and was awarded under an existing Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,907.97, is for the delivery of Valganciclovir 450 mg tablets. It is a firm fixed-price delivery order contract with a completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VALGANCICLOVIR 450 MG TABLET UD 20S. The contract has a ceiling value of $1,419.23 and a period of performance through July 7, 2025. This award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical. The IDC allows AmerisourceBergen to supply a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 450 mg valganciclovir tablets, a medication used to treat cytomegalovirus infections. The contract has a ceiling value of $2,477.97 and a performance period ending on June 17, 2025. This contract is not set aside and was competitively awarded. AmerisourceBergen...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,158,577 units of Valganciclovir 450 mg tablets in 60-count packages, with a ceiling value of $3,526.68. It is a firm fixed-price delivery order contract with a performance period ending on May 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Valganciclovir 450 mg tablets in quantities of 60 units, with a ceiling value of $12,058.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 21, 2025, with fulfillment performed from AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- This is a $127,208.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of 60-count bottles of the generic drug valganciclovir 450 mg tablets. The order has an ultimate completion date of January 9, 2025. Amerisourcebergen holds a large $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, with a ceiling value of $1,546.87, is for the supply of Valganciclovir 450 mg tablets over a period ending on June 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FS11SDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valganciclovir 450 mg tablets. The fixed-price contract has a ceiling value of $1,559.32 and a completion date of February 9, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order does not have any set-aside designation, indicating open competition. The contract covers the provision of a critical antiviral medication used in the treatment and prevention of cytomegalovirus (CMV) infections, which are common among immunocompromised patients, including those in military and veterans' healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 2/8/23 |